| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Albuterol | FAERS: 3 | US FAERS | |
| 2 | Imatinib Mesylate | FAERS: 2 | US FAERS | |
| 3 | MDV 3100 | FAERS: 2 | US FAERS | |
| 4 | Ruxolitinib phosphate | FAERS: 2 | US FAERS | |
| 5 | Anoro Ellipta | FAERS: 1 | US FAERS | |
| 6 | Estradiol | FAERS: 1 | US FAERS | |
| 7 | Lenalidomide | FAERS: 1 | US FAERS | |
| 8 | Mometasone Furoate | FAERS: 1 | US FAERS | |
| 9 | Phenobarbital | FAERS: 1 | US FAERS | |
| 10 | Quetiapine Fumarate | FAERS: 1 | US FAERS | |
| 11 | Umeclidinium bromide | FAERS: 1 | US FAERS | |
| 12 | telotristat ethyl | FAERS: 1 | US FAERS | |
| 13 | Clozapine | Canada Vigilance: 1 | Canada Vigilance | |
| 14 | cefuroxime axetil | OFFSIDES | ||
| 15 | pimecrolimus | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.